Item 7.01 Regulation FD Disclosure.

On September 11, 2012, Fluoropharma Medical, Inc. (the "Company") held a presentation at the Rodman & Renshaw Annual Global Investment Conference. The presentation included a power point presentation in the form attached hereto as Exhibit 99.1.

The information in this current report, including the presentation attached hereto as Exhibit 99.1, is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in the Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

Exhibit Description
99.1 Power point presentation

---